| |
| |
|
| Insider
Information: |
Staab Thomas R Ii |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
284,110 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,522,546 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
284,110 |
|
|
| Total
Value |
$1,522,546 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 5.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Senior Vice President ... |
2019-05-17 |
125,176 |
2011-07-01 |
0 |
Premium* |
|
|
Lensar, Inc. |
LNSR |
|
2024-05-06 |
158,934 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• – – |
2011-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
30,600 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• – – |
2012-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,989 |
41,286 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
49,864 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2013-01-31 |
4 |
A |
$1.38 |
$3,788 |
D/D |
2,745 |
52,609 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
126,218 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,900 |
171,842 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2020-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,276 |
115,657 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
131,409 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,656 |
141,787 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2024-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,000 |
158,934 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-06-17 |
4 |
AS |
$12.00 |
$37,500 |
D/D |
(3,125) |
144,301 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-06-23 |
4 |
AS |
$12.49 |
$39,031 |
D/D |
(3,125) |
144,301 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-07-01 |
4 |
AS |
$13.00 |
$40,625 |
D/D |
(3,125) |
144,301 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-05-18 |
4 |
AS |
$11.00 |
$33,000 |
D/D |
(3,000) |
162,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-06-01 |
4 |
AS |
$12.00 |
$36,000 |
D/D |
(3,000) |
159,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-06-05 |
4 |
AS |
$12.75 |
$76,500 |
D/D |
(6,000) |
153,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-06-18 |
4 |
AS |
$13.50 |
$135,025 |
D/D |
(9,700) |
149,644 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-06-19 |
4 |
AS |
$15.00 |
$100,125 |
D/D |
(6,675) |
146,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-06-22 |
4 |
AS |
$16.00 |
$60,000 |
D/D |
(3,750) |
146,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-07-20 |
4 |
AS |
$16.50 |
$57,750 |
D/D |
(3,500) |
142,644 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2016-12-19 |
4 |
AS |
$7.45 |
$24,213 |
D/D |
(3,250) |
124,187 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2017-03-06 |
4 |
AS |
$7.90 |
$25,675 |
D/D |
(3,250) |
117,313 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2017-03-08 |
4 |
AS |
$8.20 |
$54,763 |
D/D |
(6,500) |
117,313 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2017-03-10 |
4 |
AS |
$9.06 |
$29,445 |
D/D |
(3,250) |
117,313 |
0 |
- |
|
123 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
